Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q4
– Sell
-3,383
Closed -$28K – 884
2018
Q3
$28K Sell
3,383
-1,167
-26% -$12.3K ﹤0.01% 791
2018
Q2
$55K Hold
4,550
– – ﹤0.01% 692
2018
Q1
$45K Sell
4,550
-2,633
-37% -$29.6K ﹤0.01% 747
2017
Q4
$95K Sell
7,183
-12,900
-64% -$166K ﹤0.01% 803
2017
Q3
$295K Buy
20,083
+18,599
+1,253% +$1.88M 0.01% 640
2017
Q2
$155K Buy
+1,484
New +$159K ﹤0.01% 717

Other funds holding ARAV

First Quadrant's ARAV Position: Q4 2018 in Review

First Quadrant sold out of Aravive (ARAV) in Q4 2018, closing a stake of 3,383 shares — an estimated $28K sold.

First Quadrant first reported a position in ARAV in Q2 2017 and held it in 6 quarters. The position peaked at $295K in Q3 2017. 37 funds tracked by Wall St. Rank hold ARAV as of Q4 2018.

  • First Quadrant reported no remaining Aravive position as of Q4 2018 after selling out during the quarter.
  • First Quadrant sold 3,383 Aravive shares in Q4 2018, an estimated $28K.
  • First Quadrant first reported a position in Aravive in Q2 2017 and held it in 6 quarters.
  • First Quadrant's Aravive position peaked at $295K in Q3 2017.
  • 37 funds tracked by Wall St. Rank held Aravive as of Q4 2018.

Based on First Quadrant's 13F filing for Q4 2018, filed 24 Jan 2019.